Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma.
OBJECTIVE
Undifferentiated thyroid carcinoma (UTC) lacks an effective treatment. Boron neutron capture therapy (BNCT) is based on the nuclear reaction (10)B(n,alpha) (7)Li. These particles destroy the tumor locally due to their high linear energy transfer (LET). Mice transplanted with the human cell line of UTC ARO have a selective uptake of (10)B-borophenylalanine (BPA). The complete BNCT was performed to explore its possible application.


METHODS
Mice were distributed into four groups: (1) no treatment; (2) neutron beam alone; (3) 350 mg/kg body weight (b.w.) BPA plus irradiation; (4) 600 mg/kg b.w. BPA plus irradiation. Follow-up was performed by measurement of tumor volume, histologic analysis, and assessment of DNA damage using the comet assay.


RESULTS
The tumor continued to grow in Groups 1 and 2. In Group 3, a slow-down of tumor growth was observed in all mice, and a complete stop was observed in 100% of mice of Group 4. Complete disappearance of the tumor was observed in 50% of the mice that had an initial tumor volume of less than 50 mm(3) (Groups 3 and 4). DNA damage showed a progressive increase from Group 1 through 4.


CONCLUSIONS
These data show, for the first time, that UTC is amenable to treatment by BNCT.
Dagrosa
Maria Alejandra
MA
Department of Radiobiology, Constituyentes Atomic Center, Buenos Aires, Argentina.
Viaggi
Mabel
M
Longhino
Juan
J
Calzetta
Osvaldo
O
Cabrini
Romulo
R
Edreira
Martín
M
Juvenal
Guillermo
G
Pisarev
Mario Alberto
MA
D000818:Animals; D016754:Boron Neutron Capture Therapy; D002277:Carcinoma / Q000532:radiotherapy*; D020552:Comet Assay; D004249:DNA Damage; D051379:Mice; D008815:Mice, Inbred Strains; D013964:Thyroid Neoplasms / Q000532:radiotherapy*